hydroxocobalamin and Deafness

hydroxocobalamin has been researched along with Deafness* in 1 studies

Trials

1 trial(s) available for hydroxocobalamin and Deafness

ArticleYear
Controlled trial of combinations of hydroxocobalamin-cystine and riboflavine-cystine, in Nigerian ataxic neuropathy.
    Journal of neurology, neurosurgery, and psychiatry, 1974, Volume: 37, Issue:1

    Chronic cyanide intoxication of dietary origin and riboflavine deficiency are believed to be major aetiological factors in Nigerian tropical ataxic neuropathy. The results are presented of a double-blind controlled therapeutic trial of combinations of large doses of hydroxocobalamin and cystine as cyanide binding agents together with riboflavine or placebos in Nigerian patients suffering from the tropical ataxic neuropathy. No clinical benefit was demonstrable with any of the treatments.

    Topics: Ataxia; Cyanides; Cystine; Deafness; Evaluation Studies as Topic; Female; Humans; Hydroxocobalamin; Male; Middle Aged; Nigeria; Optic Atrophy; Peripheral Nervous System Diseases; Placebos; Poisoning; Riboflavin; Riboflavin Deficiency; Syndrome; Thiocyanates; Vitamin B 12

1974